A subset of neutrophils as a predictive biomarker for immunotherapy response in patients with non-small-cell lung cancer and melanoma

被引：0
|
作者：
Shaked, Yuval
Benguigui, Madeleine
Halaban, Ruth
Bacchiocchi, Antonella
Kamer, Iris
Bar, Jair
Lotem, Michal
Shen-Orr, Shai
Sznol, Mario
Cooper, Tim J.
机构：
[1] Technion, Haifa, Israel
[2] Technion Israel Inst Technol, Haifa, Israel
[3] Yale Sch Med, New Haven, CT USA
[4] Yale Univ, Sch Med, New Haven, CT USA
[5] Inst Oncol, Sheba Med Ctr, Ramat Gan, Israel
[6] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
[7] Yale Univ, Yale New Haven Hosp, Smilow Canc Hosp, Yale Canc Ctr,Sch Med, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
欧洲研究理事会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2557
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Potential biomarkers for immunotherapy in non-small-cell lung cancer
    Xing Wang
    Ziyun Qiao
    Beatrice Aramini
    Dong Lin
    Xiaolong Li
    Jiang Fan
    Cancer and Metastasis Reviews, 2023, 42 : 661 - 675
  • [32] Current status of immunotherapy for non-small-cell lung cancer
    Imbimbo, Martina
    Lo Russo, Giuseppe
    Blackhall, Fiona
    TUMORI JOURNAL, 2016, 102 (04): : 337 - 351
  • [33] Immunotherapy in non-small-cell lung cancer: a good start?
    Bogart, Jeffrey A.
    Gajra, Ajeet
    LANCET ONCOLOGY, 2014, 15 (01): : 5 - 6
  • [34] Neoadjuvant immunotherapy in resectable non-small-cell lung cancer
    Chen, Lanyi Nora
    Wei, Alexander Z.
    Shu, Catherine A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [35] Immunotherapy for non-small-cell lung cancer: current approaches
    Elisabeth Quoix
    Jean Marc Limacher
    Current Respiratory Care Reports, 2014, 3 (1): : 19 - 25
  • [36] Immunotherapy for non-small-cell lung cancer: current approaches
    Quoix, Elisabeth
    Limacher, Jean Marc
    CURRENT PULMONOLOGY REPORTS, 2014, 3 (01) : 19 - 25
  • [37] Effect and biomarker of Nivolumab for non-small-cell lung cancer
    Wang, Li
    Zhao, Deze
    Qin, Kang
    Ul Rehman, Faisal
    Zhang, Xiaochun
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
  • [38] Nuclear survivin as a biomarker for non-small-cell lung cancer
    B Lu
    A Gonzalez
    P P Massion
    Y Shyr
    B Shaktour
    D P Carbone
    D E Hallahan
    British Journal of Cancer, 2004, 91 : 537 - 540
  • [39] A subset of neutrophils activates anti-tumor immunity and inhibits non-small-cell lung cancer progression
    Tang, Zhen
    Hu, Jing
    Li, Xu-Chang
    Wang, Wei
    Zhang, Han-Yue
    Guo, Yu-Yao
    Shuai, Xin
    Chu, Qian
    Xie, Conghua
    Lin, Dandan
    Zhong, Bo
    DEVELOPMENTAL CELL, 2025, 60 (03)
  • [40] PREDICTIVE FACTORS ASSOCIATED WITH GEFITINIB RESPONSE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
    Xu, F.
    Zhou, T.
    Duan, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 47 - 47
12345